Acorah Software Products - Accounts Production 14.5.501 false true 31 May 2022 1 June 2021 false true No description of principal activity 1 June 2022 31 May 2023 31 May 2023 13415623 Dr Salina Jain - Parmar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13415623 2022-05-31 13415623 2023-05-31 13415623 2022-06-01 2023-05-31 13415623 frs-core:CurrentFinancialInstruments 2023-05-31 13415623 frs-bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 13415623 frs-bus:FilletedAccounts 2022-06-01 2023-05-31 13415623 frs-bus:Micro-entities 2022-06-01 2023-05-31 13415623 frs-bus:AuditExempt-NoAccountantsReport 2022-06-01 2023-05-31 13415623 frs-bus:Director1 2022-06-01 2023-05-31 13415623 2021-05-31 13415623 2022-05-31 13415623 2021-06-01 2022-05-31 13415623 frs-core:CurrentFinancialInstruments 2022-05-31
Registered number: 13415623
SJP Medical Locums Ltd
Financial Statements
For The Year Ended 31 May 2023
Balance Sheet
Registered number: 13415623
2023 2022
£ £
Current assets 4,095 6,285
Creditors: Amounts Falling Due Within One Year (987 ) (2,970 )
NET CURRENT ASSETS 3,108 3,315
TOTAL ASSETS LESS CURRENT LIABILITIES 3,108 3,315
NET ASSETS 3,108 3,315
CAPITAL AND RESERVES 3,108 3,315

Notes

1. General Information
SJP Medical Locums Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13415623 . The registered office is 7 Wike Ridge View, Leeds, LS17 9NS.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
1 1
Page 0
Page 1
For the year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Salina Jain - Parmar
Director
15/03/2024